| 中文名称 | 利福平 |
|---|---|
| 中文别名 | 利福平;甲哌力复霉素;利福霉素-S;3-(((4-甲基-1-哌嗪基)亚氨基)甲基)-利福霉素;异丁哌力复霉素;异丁基哌嗪利福霉素;利福霉素SV;力复霉素SV;利福霉素SV钠;利福;利福定;利福霉素;利福平 EP标准品;利福平 USP标准品;利福平 标准品;利福平杂质对照品;利福平(低温保存);利福平-13C-D3;3-[[(4-甲基-1-哌嗪基)亚氨基]甲基]-利福霉素;甲哌利福霉素;抗厌氧菌药;树脂天青;3-(4-甲基-1-哌嗪基亚胺甲基)利福霉素SV;利米定;雷發平;力复平;立福平;力复霉素;利福平粉;利福平晶体;Rifampicin 利福平;利福平溶液 |
| 英文名称 | Rifampicin |
| 英文别名 | rifampicin;3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin;Abrifam;Dipicin;Eremfat;RIF;Rifa;Rifadin;Rifadin I.V.;Rifaldin;rifaldazine;Rifamate;Rifamicin AMP;Rifampin;Rifaprodin;Rifater;Rifobac;Rifoldin;Riforal;Rimactan;Rimycin;Rifamycin SV;Rifamycin SV Sodium;Rifandin;3-(4-METHYLPIPERAZINYLIMINOMETHYL)RIFAMYCIN SV;RIFAMPICIN(RG);3-(4-Methylpiperazinyliminomethyl)rifamycin SV,Rifampin,Rifamycin AMP;AMP;arficin;FaMcin;Resazurin;rifagen;Rifamycin AMP;rifinah;3-[[(4-methyl-1-piperazinyl)imino]methyl]-rifamycin;ARHF;RHOF;l-5103;Rimactane;Rifampicinum;Tubocin;Rifoldine;Rimactizid;Archidyn;Rimazid;Rifampicin SV;R/AMP;Rifampicina;Rifamor;Benemicin;Sinerdol;Rifadine;Rifaldazin;Rimactazid;Fenampicin;Doloresum;Rifcin;Arzide;Rifam;Dione 21-acetate;Rifampicine [French];Rifampicinum [INN-Latin];Ba 41166/E;Rifampicina [INN-Spanish];3-(((4-Methyl-1-piper;SR-05000002118-3;5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate;HMS3713J11;2,7-(EPOXYPENTADECA(1,11,13)TRIENIMINO)NAPHTHO(2,1-B)FURAN-1,11(2-H)-DIONE, 5,6,9,17,19,21-HEXAHYDROXY-23-METHOXY-2,4,12,1///;RIFAMPICIN [INN];Rimactane (TN);rifamcin;Reserpine & Rifampicin;HMS1569J11;Rifamsolin;BDBM50370232;GR-306;Rifampicin, European Pharmacopoeia (EP) Reference Standard;RIFAMPICIN (IARC);RIFAMPICIN (EP IMPURITY);RIFAMPICIN [JAN];RIFAMYCIN AMP [MI];C06688;D00211;Rifampicine;(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(4-methylpiperazin-1-yliminomethyl)-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-21-yl acetate;RIFAMPIN COMPONENT OF RIFATER;Rifampicin, >=97% (HPLC), powder;Rifampicin in combination with actinonin, BB-3497, hydroxylamine hydrochloride, and 1,10-phenanthroline;NSC-113926;CHEMBL374478;2,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate;NCGC00022678-03;Rifampin, United States Pharmacopeia (USP) Reference Standard;RIFAMPIN COMPONENT OF RIFAMATE;AZT + Rifampin;BA-41166/E;Rifampicin & EEP;8CI);3-(((4-METHYL-1-PIPERAZINYL)IMINO)METHYL)RIFAMYCIN;8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin;RIFAMPIN (USP MONOGRAPH);BPBio1_000561;Prestwick3_000525;CCG-208267;BA 411661E;yl]-, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-;Rifampin (Rifampicin);3-((4-METHYL-1-PIPERAZINYL)IMINOMETHYL)RIFAMYCIN SV;RIFAMPIN [MI];Rifampin [USAN];Spectrum5_002018;3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV;3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin;(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-... |
| CAS No. | 13292-46-1 |
| 分子式 | C43H58N4O12 |
| 分子量 | 822.94 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学